LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Entered into agreement with Bristol Myers Squibb for mavacamten in China and other Asian marketsPhase 3 data from EXPLORER-CN trial of mavacamten presented in an oral late-breaking science session at...

Related Keywords

China ,Hong Kong ,Thailand ,Macau ,Taiwan ,United States ,Shanghai ,Singapore ,Chinese ,Yizhe Wang ,Bristol Myers Squibb ,Katherine Smith ,Research Development Expenses ,Globenewswire Inc ,Astrazeneca ,European Society For Medical Oncology ,Exchange Commission ,European Society Of Cardiology ,European Society Of Cardiology Congress ,Clinical Development Updates ,Myokardia Inc ,Myers Squibb ,Cardiology Congress ,Chinese Demodex ,Chief Executive Officer ,Business Highlights ,Mainland China ,Medical Oncology ,Annual Report ,